United States v. Gonzalez

113 F.4th 140
Court of Appeals for the First Circuit·Decided August 26, 2024·No. 24-1070·Published·Cited by 1 cases

Opinion

United States Court of Appeals For the First Circuit

No. 24-1070 UNITED STATES OF AMERICA, Appellant,

v.

CARLOS GONZALEZ,

Defendant, Appellee.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS

[Hon. Mark G. Mastroianni, U.S. District Judge]

Before

Gelpí and Rikelman, Circuit Judges, and Katzmann,* Judge.

Donald C. Lockhart, Assistant United States Attorney, with whom Joshua S. Levy, Acting United States Attorney, was on brief, for appellant.

Linda J. Thompson, with whom James R. Goodhines, Goodhines Law Offices, and Thompson & Thompson, P.C. were on brief, for appellee.

August 26, 2024

* Of the United States Court of International Trade, sitting by designation.

RIKELMAN, Circuit Judge. After the government searched the house where Carlos Gonzalez lived for evidence of an illegal pill-making operation, Gonzalez moved to suppress the evidence found during the search. The district court granted his motion, concluding that the critical facts supporting the search warrant application were too "stale" and that the affidavit was otherwise so bare bones that no reasonable officer could have relied on the warrant. The court pointed out that according to the affidavit, the mastermind of the pill-making operation had moved out of that same house four and a half months earlier, there was little (if any) suspicious activity at the house after his move, and the pill-making equipment was highly portable.

The government appeals, arguing that the facts in the affidavit were enough to justify a finding of probable cause, and, in any event, they were not so conclusory that a reasonable officer could not rely on the warrant. Thus, the government asks us to reverse the district court's ruling suppressing the evidence from the search.

We agree with the government. Although we elect to bypass the district court's probable-cause determination, which we view as a close call, we find that a reasonable officer could have relied on the warrant in good faith. As the government argues, based on the facts in the affidavit, a reasonable officer could have concluded that the leader of the pill-making operation had

every reason to keep the operation where it had been successful for years -- the house where Gonzalez continued to live. Thus, we vacate the district court's ruling on the motion to suppress and remand for further proceedings.

I. BACKGROUND

Before diving into the details of the lengthy search warrant affidavit, we summarize the key facts. On January 20, 2022, Drug Enforcement Administration (DEA) Special Agent Scott Smith applied for a warrant to search a three-story, two-family house at 8 Mereline Avenue in East Longmeadow, Massachusetts. In his affidavit supporting the warrant application, he described the DEA's four-year investigation into a pill-making operation that distributed counterfeit oxycodone pills containing fentanyl and heroin. According to Smith, the operation ran out of two locations: the 8 Mereline Avenue house, owned by Michael Matos and his wife Neysha, and an auto-repair shop in nearby Agawam, owned by Hector Ramos.

Smith went on to describe how Michael Matos oversaw the production of the counterfeit pills in the basement of 8 Mereline Avenue. According to Smith, Matos used tableting machines and binding agents to process heroin and fentanyl into pills. To make the pills resemble oxycodone tablets, Matos used dyes and imprinted the pills with letters and numbers that typically signify certain dosages of oxycodone. Smith explained that Gonzalez and Matos

then supplied the fentanyl and heroin pills to Ramos, who stored the pills and sold them from his auto-repair shop.

Critically for this case, Matos and his wife lived on the second floor of 8 Mereline Avenue until September 2021, when they moved to a new home about fifteen minutes away in Somers, Connecticut. The Matos family continued to own 8 Mereline Avenue and visit the house after they relocated, and no one else moved into the second-floor unit. Meanwhile, Gonzalez, who had lived on the first floor of 8 Mereline Avenue since at least June 2020, continued to reside in the house with his girlfriend Kiara Rodriguez-Santiago, including on the date of the search in late January 2022.

In his warrant application to the magistrate judge, Smith sought to search both 8 Mereline Avenue and Ramos's auto-body shop. He stated that there was probable cause to believe that both locations were being used in connection with a drug operation and that drugs, paraphernalia for processing and distributing drugs, and cash proceeds would be found in both places.

DEA agents executed the search warrant for 8 Mereline Avenue on January 25, 2022. They seized, among other things, 5,000-6,000 counterfeit oxycodone pills containing fentanyl, two firearms, two magazines with several rounds of ammunition, and equipment and supplies for making counterfeit pills. This

equipment included pill-press parts, dye molds for stamping pills, and counterfeit oxycodone labels.

With this factual overview in place, we proceed to discuss the details of the DEA investigation as described in Smith's affidavit, citing "only those facts necessary to put the probable-cause [and good-faith] issue into workable perspective." United States v. Rivera, 825 F.3d 59, 61 (1st Cir. 2016).

A. The DEA Investigation

Federal agents began to investigate Matos's pill-making operation in early 2018, four years before the warrant was issued, when pills containing heroin were discovered inside a toolbox repossessed from Matos. Those pills were marked with "M" on one side and "30" on the other -- the same markings used by an FDA-registered drug manufacturer for its thirty milligram oxycodone tablets. A few months later, officers with the East Longmeadow Police Department, who were helping with the federal investigation, conducted two traffic stops near "the area" of 8 Mereline Avenue. During the first stop, officers recovered counterfeit oxycodone tablets. During the second stop, an officer discovered about twelve grams of heroin in the possession of a driver who had links to Matos.

Smith's affidavit in support of the search warrant features accounts from two confidential informants (CIs), including one who saw Matos's operation in action in the basement

of 8 Mereline Avenue. The two CIs cooperated with law enforcement after they were arrested on April 5, 2021, in connection with a separate fentanyl-pill-processing operation in Springfield, Massachusetts. One of the informants (CI-2) explained that, in early 2020, he and his partner (CI-1) learned that a person named "Mikey" was making a significant profit from manufacturing and selling counterfeit oxycodone tablets -- an operation that they decided to replicate. CI-2 first met Mikey at Ramos's auto-repair shop, where Mikey brought out a tableting machine and showed CI-2 how it worked. CI-2 stated that Mikey carried the tableting machine in a large suitcase wrapped in a comforter and that he had a second suitcase that contained "all of the other processing equipment." CI-2 then explained how he met with Mikey three times at Mikey's residence. Each time he went to Mikey's residence, CI-2 brought ten to twenty grams of heroin, which Mikey would mix and process into counterfeit oxycodone tablets using a pill-press machine in the basement, charging CI-2 between eight and nine dollars per pill. Using a map on an agent's cell phone, CI-2 showed agents that Mikey's residence was on Mereline Avenue. According to CI-2, the last time he met with Mikey on Mereline Avenue was in April or May of 2020, about one year and nine months before the search warrant here was issued.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Gonzalez, 113 F.4th 140 (1st Cir. 2024).

113 F.4th 140 (United States v. Gonzalez) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Daigle
First Circuit, 2026
United States v. Coleman
First Circuit, 2025